Even though BC supplementation could regulate these genes in a sex-dependent manner independently of its effects on miRNAs, it is remarkable that both hepatic miR-122 levels and the mRNA levels of validated or proposed miR-122 target genes such as Klf6 and Vegf were sex-dependently affected by the BC treatment. This evidence concerns the gene VEGFA and breast cancer.